InMed Pharmaceuticals Inc. - 8-K Filing
InMed Pharmaceuticals amends merger agreement with Mentari Therapeutics to clarify transaction sequencing, tax treatment, and potential pre-closing financing (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $INM